Cancer Investigation

Subscription or hybridMedicine

Cost to publish

Subscription

No open-access fee found. Publishing is typically free to the author.

Time to publication

Not reported to DOAJ.

h-index

114

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

1.9

Average citations to articles from the previous two years.

What it costs to publish here

We could not find a published fee for Cancer Investigation. As a subscription or hybrid journal, publishing is normally free unless you choose the open-access option.

Peer review and licensing

Review modelNot reported
LicenceNot reported
Author keeps copyrightNot reported
Plagiarism screeningNot reported
Editorial boardNot linked in DOAJ
LanguagesNot reported

Verification checks

2 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsNot listed. Many legitimate subscription journals are not in DOAJ, so this alone means little.Not confirmed
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.Confirmed
  • Peer review model publicly declaredNo declared model found in DOAJ.Not confirmed
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.Not confirmed
  • Screens submissions for plagiarismReported to DOAJ by the journal.Not confirmed
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.Not confirmed
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.Not confirmed
  • Still actively publishingMost recent indexed article: 2026.Confirmed

Scope

The subjects Cancer Investigation publishes most, derived from the topics assigned to its indexed articles.

Cancer Treatment and PharmacologyLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesLymphoma Diagnosis and TreatmentBreast Cancer Treatment StudiesCancer-related Molecular PathwaysHER2/EGFR in Cancer ResearchImmunotherapy and Immune ResponsesCancer Genomics and DiagnosticsLung Cancer Research Studies

Publication record

Indexed articles4,190
Total citations87,991
i10-index2,053
Most recent indexed article2026
All ISSNs0735-7907, 1532-4192

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.